Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001863567 | SCV002108793 | likely benign | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71 | 2024-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003164055 | SCV003875230 | uncertain significance | Inborn genetic diseases | 2023-02-22 | criteria provided, single submitter | clinical testing | The c.877G>A (p.A293T) alteration is located in exon 9 (coding exon 9) of the IFT172 gene. This alteration results from a G to A substitution at nucleotide position 877, causing the alanine (A) at amino acid position 293 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005023295 | SCV005651489 | uncertain significance | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71; Bardet-Biedl syndrome 20 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004738398 | SCV005345558 | uncertain significance | IFT172-related disorder | 2024-05-18 | no assertion criteria provided | clinical testing | The IFT172 c.877G>A variant is predicted to result in the amino acid substitution p.Ala293Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.14% of alleles in individuals of East Asian descent in gnomAD. Although we suspect that this variant may be benign, the clinical significance of this variant is classified as uncertain at this time due to insufficient functional and genetic evidence. |